-
"Who Owns Truth?" - Biomedical Research in a Health Policy Context
Online Presentations | 30 Mar 2009 | Contributor(s):: Samuel A. Richmond
This presentation examines a claim made by PhRMA on behalf of pharmaceutical manufacturing companies of America, and the response of the International Committee of Medical Journal Editors (ICMJE) questioning drug company publication policies and practices. Also considered are changes in law...
-
So What do Biologist, Biotechnologists & Pharmaceutical Scientist Want With an AFM/SPM Anyway?
Online Presentations | 11 Sep 2008 | Contributor(s):: Kunal Bose
-
Micro-fabricated Biosensors for Cardiac Diagnostics
Online Presentations | 30 Jul 2008 | Contributor(s):: V.Ramgopal Rao
In this talk the current status of an ongoing effort in the Electrical Engineering Department at IIT Bombay on the development of an integrated systems to provide point-of-care diagnostic support for cardiovascular diseases will be presented. The system under development monitors the molecular...
-
Self-association of peptides and proteins: Retrospect and prospects
Online Presentations | 30 Jul 2008 | Contributor(s):: R. Nagaraj
The ability of peptides and proteins to form aggregates was known from the dawn of protein and peptide chemistry! It was often considered a nuisance and attention was directed towards disaggregating them to ensure dissolution particularly in aqueous solution. X-ray crystallography has indicated...
-
Nanohybrids as Sensors and Superstructures
Online Presentations | 30 Jul 2008 | Contributor(s):: K. George Thomas
We have recently initiated a detailed research program on the design of nanoparticle conjugates of organic/inorganic molecules which enable the coupling of the intrinsic functionalities of molecular systems (binding, self-assembly, switching etc.) with the size and shape dependent optoelectronic...
-
Transforming Pharmaceutical Manufacturing in the 21st Century – Indiana as a Center for Biopharmaceutical Manufacturing
Online Presentations | 21 Jul 2008 | Contributor(s):: Craig K. Svensson
The pharmaceutical industry is moving from a model of fully integrated pharmaceutical companies to fully networked pharmaceutical companies. In this latter model, major pharmaceutical companies are increasingly relying on partnerships for critical elements in the drug development process. This...
-
Quality by Design and Process Analytical Technology for Pharmaceutical Manufacturing in the 21st Century
Online Presentations | 21 Jul 2008 | Contributor(s):: Stephen R. Byrn
PAT or Process Analytical Technology is an initiative and guidance from the U.S. FDA to encourage modernization of pharmaceutical manufacturing. In reality, PAT is a subset of the larger concept of Quality by Design which is the implementation of design concepts for pharmaceutical dosage forms...
-
Discovery Park at Purdue University: Engine for Academic and Commercial Growth
Online Presentations | 10 Jul 2008 | Contributor(s):: Charles Buck, Pankaj Sharma
The Bindley Bioscience Center and Birck Nanotechnology Center at Discovery Park blend life sciences and engineering research to cultivate and support innovative, multi-investigator, interdisciplinary research teams. Discovery Park engages researchers in a broader perspective with applications of...
-
Pharmaceutical Manufacturing – Present and Future and What Should be the Role of India?
Online Presentations | 10 Jul 2008 | Contributor(s):: Prabir K. Basu
Pharmaceutical manufacturing is at a crossroads. There is widespread realization among the regulators and the industry that the current state of high variability and “Quality by Inspection” is no longer adequate. While the industry still largely employs first generation quality management tools,...